Report Detail
Global Antiepileptic Drugs Market Insights, Forecast to 2025
- RnM3515248 |
- 11 June, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures.
The global Antiepileptic Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antiepileptic Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Antiepileptic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antiepileptic Drugs in these regions.
This research report categorizes the global Antiepileptic Drugs market by top players/brands, region, type and end user. This report also studies the global Antiepileptic Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Johnson & Johnson
Sanofi
Pfizer
Novartis
Abbott
Sunovion
Cephalon (Teva)
Market size by Product
First generation
Second generation
Market size by End User
Hosptial
Clinic
Research
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antiepileptic Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antiepileptic Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antiepileptic Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antiepileptic Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antiepileptic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antiepileptic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antiepileptic Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antiepileptic Drugs Market Size Growth Rate by Product
- 1.4.2 First generation
- 1.4.3 Second generation
- 1.5 Market by End User
- 1.5.1 Global Antiepileptic Drugs Market Size Growth Rate by End User
- 1.5.2 Hosptial
- 1.5.3 Clinic
- 1.5.4 Research
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antiepileptic Drugs Market Size
- 2.1.1 Global Antiepileptic Drugs Revenue 2014-2025
- 2.1.2 Global Antiepileptic Drugs Sales 2014-2025
- 2.2 Antiepileptic Drugs Growth Rate by Regions
- 2.2.1 Global Antiepileptic Drugs Sales by Regions
- 2.2.2 Global Antiepileptic Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antiepileptic Drugs Sales by Manufacturers
- 3.1.1 Antiepileptic Drugs Sales by Manufacturers
- 3.1.2 Antiepileptic Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Antiepileptic Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Antiepileptic Drugs Revenue by Manufacturers
- 3.2.1 Antiepileptic Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Antiepileptic Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Antiepileptic Drugs Price by Manufacturers
- 3.4 Antiepileptic Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Antiepileptic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antiepileptic Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Antiepileptic Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antiepileptic Drugs Sales by Product
- 4.2 Global Antiepileptic Drugs Revenue by Product
- 4.3 Antiepileptic Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antiepileptic Drugs Breakdown Data by End User
6 North America
- 6.1 North America Antiepileptic Drugs by Countries
- 6.1.1 North America Antiepileptic Drugs Sales by Countries
- 6.1.2 North America Antiepileptic Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antiepileptic Drugs by Product
- 6.3 North America Antiepileptic Drugs by End User
7 Europe
- 7.1 Europe Antiepileptic Drugs by Countries
- 7.1.1 Europe Antiepileptic Drugs Sales by Countries
- 7.1.2 Europe Antiepileptic Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antiepileptic Drugs by Product
- 7.3 Europe Antiepileptic Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Antiepileptic Drugs by Countries
- 8.1.1 Asia Pacific Antiepileptic Drugs Sales by Countries
- 8.1.2 Asia Pacific Antiepileptic Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antiepileptic Drugs by Product
- 8.3 Asia Pacific Antiepileptic Drugs by End User
9 Central & South America
- 9.1 Central & South America Antiepileptic Drugs by Countries
- 9.1.1 Central & South America Antiepileptic Drugs Sales by Countries
- 9.1.2 Central & South America Antiepileptic Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antiepileptic Drugs by Product
- 9.3 Central & South America Antiepileptic Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antiepileptic Drugs by Countries
- 10.1.1 Middle East and Africa Antiepileptic Drugs Sales by Countries
- 10.1.2 Middle East and Africa Antiepileptic Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antiepileptic Drugs by Product
- 10.3 Middle East and Africa Antiepileptic Drugs by End User
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Antiepileptic Drugs Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Johnson & Johnson Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Johnson & Johnson Antiepileptic Drugs Products Offered
- 11.2.5 Johnson & Johnson Recent Development
- 11.3 Sanofi
- 11.3.1 Sanofi Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi Antiepileptic Drugs Products Offered
- 11.3.5 Sanofi Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Antiepileptic Drugs Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 Novartis
- 11.5.1 Novartis Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Novartis Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Novartis Antiepileptic Drugs Products Offered
- 11.5.5 Novartis Recent Development
- 11.6 Abbott
- 11.6.1 Abbott Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Abbott Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Abbott Antiepileptic Drugs Products Offered
- 11.6.5 Abbott Recent Development
- 11.7 Sunovion
- 11.7.1 Sunovion Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sunovion Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sunovion Antiepileptic Drugs Products Offered
- 11.7.5 Sunovion Recent Development
- 11.8 Cephalon (Teva)
- 11.8.1 Cephalon (Teva) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Cephalon (Teva) Antiepileptic Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Cephalon (Teva) Antiepileptic Drugs Products Offered
- 11.8.5 Cephalon (Teva) Recent Development
12 Future Forecast
- 12.1 Antiepileptic Drugs Market Forecast by Regions
- 12.1.1 Global Antiepileptic Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antiepileptic Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Antiepileptic Drugs Market Forecast by Product
- 12.2.1 Global Antiepileptic Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Antiepileptic Drugs Revenue Forecast by Product 2019-2025
- 12.3 Antiepileptic Drugs Market Forecast by End User
- 12.4 North America Antiepileptic Drugs Forecast
- 12.5 Europe Antiepileptic Drugs Forecast
- 12.6 Asia Pacific Antiepileptic Drugs Forecast
- 12.7 Central & South America Antiepileptic Drugs Forecast
- 12.8 Middle East and Africa Antiepileptic Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antiepileptic Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antiepileptic Drugs . Industry analysis & Market Report on Antiepileptic Drugs is a syndicated market report, published as Global Antiepileptic Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antiepileptic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
